Chinese pharmaceutical group WuXi Vaccines is to create 200 jobs in Dundalk over the next five years.
The roles are being developed as part of a $240m (€2017m) investment in a vaccine production facility on the newly established WuXi Biologics Campus in Dundalk.
It will bring total employment on the site to 600 by 2024.
The Government is supporting the investment through IDA Ireland.
Minister for Business, Enterprise & Innovation Heather Humphreys described the news as “a huge vote of confidence in the local workforce.”
WuXi Vaccines is a joint venture between WuXi Biologics and Hile Bio-pharmaceutical.
The company has entered into the strategic partnership with a global vaccine leader under which WuXi Vaccines will build a dedicated facility to supply a commercial product for the global market.
The construction of the WuXi Biologics contract manufacturing facility on the county Louth campus, which is scheduled for commercial production in 2022, is underway and it is currently hiring for senior roles.
It has been designed to be the world’s largest biologics contract manufacturing facility using single-use and flexible scale-out production technology.